Patient Focused Discovery Driven

Exagen uses advanced computational approaches to develop tests for use in clinical laboratories & pharmaceutical development.

Coperna®: Our proprietary computational technology gives us the ability to analyze vast numbers of possible combinations of genes to discover those combinations that are most meaningful for disease-specific diagnosis, prognosis or treatment response.

Exagen is not limited to delivering tests within a particular disease category or test platform. Rather, Exagen's delivery system allows for its assays to be brought to market on the most convenient and effective testing platform appropriate for the assay.